Healthcare Industry News: Novation
News Release - June 5, 2012
HYCOR Awarded with Novation Supplier AgreementAgreement Provides More Than 65,000 Healthcare Members Served by Novation with the Ability to Purchase Allergy and Autoimmune Testing from HYCOR
GARDEN GROVE, Calif., June 5, 2012 -- (Healthcare Sales & Marketing Network) -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products, today announced that it has been awarded a two year supplier agreement, effective June 1, 2012, by Novation – the leading healthcare supply chain expertise and contracting company for the more than 65,000 members of VHA Inc. and UHC, two national healthcare alliances, and Provista, LLC. The two-year agreement will provide the healthcare members Novation serves with access to allergy and autoimmune laboratory testing from HYCOR.
"Our nearly 30 years in the in vitro allergy and autoimmune testing market translates to value beyond the test for the members served by Novation," said Dick Aderman, CEO, HYCOR. "We are pleased to work with Novation to offer the members these important allergy and autoimmune testing options at a competitive price."
Allergy disease is the fifth leading chronic disease in the United States, with an estimated 60 million Americans (roughly 1 in 5) suffering from one or more allergy types. The symptoms of allergy can appear in the nose, ears, lungs, skin, digestive system or all over. Early diagnosis and treatment of allergy have been shown to modify the course of the disease and help prevent subsequent development of other more serious conditions.
An autoimmune disorder is a condition that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders and diagnosis is a complex process.
About HYCOR Biomedical, Inc.
Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro diagnostics products. Since its founding, HYCOR has expanded its presence into urinalysis, allergy and autoimmune products used in clinical laboratories, hospitals and doctors' offices worldwide. Among its products, HYCOR markets the HYTEC™, KOVA® and AUTOSTAT™ brands. The company is focused on delivering products that provide the highest value to clinicians through innovation, reliability and customer service. For more information, please visit www.hycorbiomedical.com.
Source: HYCOR Biomedical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.